Antibody-Drug Conjugates: The New Frontier of Chemotherapy

Antibody-Drug Conjugates: The New Frontier of Chemotherapy

In recent years, antibody-drug conjugates (ADCs) have become promising antitumor agents to be used as one of the tools in personalized cancer medicine. ADCs are comprised of a drug with cytotoxic activity cross-linked to a monoclonal antibody, targeting antigens expressed at higher levels on tumor c...

Full description

Bibliographic Details
Main Authors: Sara Ponziani, Giulia Di Vittorio, Giuseppina Pitari, Anna Maria Cimini, Matteo Ardini, Roberta Gentile, Stefano Iacobelli, Gianluca Sala, Emily Capone, David J. Flavell, Rodolfo Ippoliti, Francesco Giansanti
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
Mabs
Antibody-Drug Conjugate
cancer therapy
drug targeting
payload
cross-linking
Online Access:https://www.mdpi.com/1422-0067/21/15/5510

Internet

https://www.mdpi.com/1422-0067/21/15/5510

Similar Items